Internal Medicine, Endocrinology, Diabetes, & Metabolism · Indianapolis, IN
NPI
1427079672
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8101 Clearvista Pkwy Ste 185
Indianapolis, IN, 46256
Phone (317) 621-1006
Groups this clinician bills Medicare through
Medicare paid, 2024
$787K
34,032 services
Medicare patients, 2024
824
Average age 73
Drug cost, 2024
$6.0M
8,261 prescriptions
Company payments, 2025
$140K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ernest Asamoah was code J3111 (injection, romosozumab-aqqg, 1 mg), 22,050 times for 20 patients. In total Ernest Asamoah billed 34,032 services in 26 codes, and Medicare paid $787K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 22,050 | 20 | $8.58 | $189K |
| J0897 Injection, denosumab, 1 mg | Office | 9,420 | 92 | $20.09 | $189K |
| 99214 Office E&M - Established | Office | 637 | 501 | $80.15 | $51K |
| 96372 Injection Administration | Office | 287 | 110 | $9.11 | $2,614 |
| 76536 Ultrasound - Nonspecific | Office | 142 | 140 | $66.83 | $9,490 |
| 95251 Test - Miscellaneous | Office | 134 | 104 | $24.99 | $3,349 |
| 99213 Office E&M - Established | Office | 117 | 113 | $58.35 | $6,827 |
| 99215 Office E&M - Established | Office | 88 | 83 | $114.58 | $10K |
| 10005 Other Organ Systems | Office | 64 | 63 | $87.40 | $5,594 |
| 99203 Office E&M - New | Office | 61 | 61 | $68.23 | $4,162 |
| 99451 E&M - Miscellaneous | Office | 42 | 42 | $22.14 | $930 |
| 99202 Office E&M - New | Office | 37 | 37 | $50.22 | $1,858 |
| 10006 Other Organ Systems | Office | 25 | 25 | $40.95 | $1,024 |
| 99204 Office E&M - New | Office | 23 | 23 | $102.26 | $2,352 |
| 83036 Blood Count | Office | 19 | 18 | $9.52 | $181 |
By year: 2022 $691K for 36,597 services; 2023 $704K for 31,504 services; 2024 $787K for 34,032 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 19 | 18 | $9.52 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Ernest Asamoah prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,111 prescriptions and refills. In total Ernest Asamoah wrote 8,261 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,111 | 2,939 | 291 | $9,743 |
| Mounjaro Tirzepatide | 693 | 859 | 117 | $893K |
| Ozempic Semaglutide | 380 | 724 | 87 | $698K |
| Jardiance Empagliflozin | 376 | 768 | 92 | $443K |
| Synthroid Levothyroxine Sodium | 354 | 889 | 100 | $36K |
| Tresiba Flextouch U-200 Insulin Degludec | 312 | 668 | 85 | $483K |
| Farxiga Dapagliflozin Propanediol | 280 | 525 | 54 | $294K |
| Metformin Hcl Generic | 254 | 712 | 77 | $1,992 |
| Metformin Hcl Er Metformin Hcl | 191 | 563 | 62 | $1,443 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 187 | 403 | 81 | $19K |
| Atorvastatin Calcium Generic | 180 | 518 | 48 | $1,591 |
| Methimazole Generic | 174 | 466 | 55 | $1,421 |
| Liothyronine Sodium Generic | 165 | 434 | 49 | $7,562 |
| Unithroid Levothyroxine Sodium | 150 | 436 | 46 | $9,036 |
| Rosuvastatin Calcium Generic | 134 | 397 | 43 | $2,394 |
Brand drugs: 4,539 claims; generic drugs: 3,180 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ernest Asamoah $140K ($140K in general payments such as food, travel and fees) from 34 companies. The largest payer was Novo Nordisk Inc with $44K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 52 | $44K |
| Amgen Inc. AMGN | 70 | $32K |
| Lilly USA, LLC LLY | 51 | $29K |
| Dexcom, Inc. DXCM | 11 | $9,183 |
| Chiesi USA, Inc. | 9 | $6,511 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $6,506 |
| Alexion Pharmaceuticals, Inc. AZN | 13 | $5,369 |
| Abbvie Inc. ABBV | 14 | $4,079 |
| Mannkind Corporation MNKD | 15 | $603 |
| Corcept Therapeutics CORT | 24 | $416 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.